title: Placebo-controlled comparison between a single dose and a multidose of betamethasone in accelerating lung maturation of mice offspring.
abstract: OBJECTIVE
  Our purpose was to determine, in a placebo-controlled manner with a mouse model, whether a multidose of betamethasone is more beneficial than a single dose in accelerating fetal lung maturation.
  
  
  METHODS
  Ninety gravid CD-1 mice were randomly assigned to 1 of 3 groups (n = 30) to receive either a placebo (0.25 mL subcutaneously) or betamethasone (0.1 mg subcutaneously) as a single dose on gestational day 14 or as a multidose twice daily on gestational day 14 and 15. Ten pregnancies in each group were terminated at gestational day 16.5 to observe the neonatal breathing pattern (scale 0 to 5; 5 is unlabored breathing) and the lung histologic findings (scale 0 to 5; 5 is alveolar budding). The lungs of the offspring belonging to the remaining 20 pregnancies in each group were removed and weighed at postnatal day 1, 3, 5, or 120.
  
  
  RESULTS
  Fetuses exposed to a multidose of betamethasone displayed a higher breathing score at gestational day 16.5 than either to a single dose or to the placebo (mean score 4.6 vs 3.8 or 1.3; P <. 001). Alveolar development was greater after exposure to a multidose of betamethasone than after a single dose or after a placebo (mean score 4.4 vs 3.5 or 1.6; P <.001). The lung weights at gestational day 16.5 were less after a multidose of betamethasone than after a single dose of either betamethasone or a placebo (18.3 +/- 1.0 g vs 21.4 +/- 1.3 g or 23.3 +/- 1.3 g; P <.02). The lung/body weight ratio was similarly affected. This reduced weight of the lungs persisted postnatally into adulthood.
  
  
  CONCLUSIONS
  With a CD-1 mouse model, a multidose of antenatal betamethasone accelerated fetal lung maturation more than after a single dose but was accompanied with a decrease in lung weight that persisted into adulthood.
authors.affiliation: Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Stewart
authors.forename: A E
authors.initials: AE
authors.lastname: Sienko
authors.forename: C L
authors.initials: CL
authors.lastname: Gonzalez
authors.forename: H D
authors.initials: HD
authors.lastname: Christensen
authors.forename: W F
authors.initials: WF
authors.lastname: Rayburn
mesh_terms: D000818:Animals; D000831:Animals, Newborn / Q000033:anatomy & histology / Q000502:physiology; D001623:Betamethasone / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects*; D005865:Gestational Age; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000627:therapeutic use; D008168:Lung / Q000033:anatomy & histology / Q000187:drug effects / Q000196:embryology*; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010919:Placebos; D012119:Respiration / Q000187:drug effects
chemical_list: D005938:Glucocorticoids; D010919:Placebos; D001623:Betamethasone